Bristol Myers Squibb has announced a $2.3 billion investment in a new state-of-the-art pharmaceutical manufacturing campus at Houston’s Generation Park, expected to create nearly 500 skilled jobs and approximately 2,000 construction and indirect jobs between 2027 and 2030. The 600,000-square-foot facility will use advanced digital technology and flexible manufacturing capabilities to accelerate the production of next-generation medicines, strengthening Houston’s growing life sciences industry and reinforcing the region’s position as a hub for healthcare innovation and economic development.
713-782-3777
